and Soleno Therapeutics. According to TipRanks, Gon Ha has an average return of 3.1% and a 46.47% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst ...

"Alongside spending decisions taken at the Budget and the re-setting of departmental budgets, the Deputy Prime Minister and I ...

ALT5 Prime is an electronic over-the-counter trading platform ... The Company is working on the separation of our biotech business that will become known as 'Alyea Therapeutics.' Forward Looking ...

Encouraging Preclinical Data: Decoy20 has produced efficacy in preclinical studies across a variety of tumor types and in combination with four different classes of existing drugs, demonstrating both ...